Nishijima H, Nishitani H, Seki T, Nishimoto T
Department of Molecular Biology, Graduate School of Medical Science, Kyushu University, Fukuoka 812-82, Japan.
J Cell Biol. 1997 Sep 8;138(5):1105-16. doi: 10.1083/jcb.138.5.1105.
By incubating at 30 degrees C in the presence of an energy source, p34(cdc2)/cyclin B was activated in the extract prepared from a temperature-sensitive mutant, tsBN2, which prematurely enters mitosis at 40 degrees C, the nonpermissive temperature (Nishimoto, T. , E. Eilen, and C. Basilico. 1978. Cell. 15:475-483), and wild-type cells of the hamster BHK21 cell line arrested in S phase, without protein synthesis. Such an in vitro activation of p34(cdc2)/cyclin B, however, did not occur in the extract prepared from cells pretreated with protein synthesis inhibitor cycloheximide, although this extract still retained the ability to inhibit p34(cdc2)/cyclin B activation. When tsBN2 cells arrested in S phase were incubated at 40 degrees C in the presence of cycloheximide, Cdc25B, but not Cdc25A and C, among a family of dual-specificity phosphatases, Cdc25, was lost coincidentally with the lack of the activation of p34(cdc2)/cyclin B. Consistently, the immunodepletion of Cdc25B from the extract inhibited the activation of p34(cdc2)/cyclin B. Cdc25B was found to be unstable (half-life < 30 min). Cdc25B, but not Cdc25C, immunoprecipitated from the extract directly activated the p34(cdc2)/cyclin B of cycloheximide-treated cells as well as that of nontreated cells, although Cdc25C immunoprecipitated from the extract of mitotic cells activated the p34(cdc2)/cyclin B within the extract of cycloheximide-treated cells. Our data suggest that Cdc25B made an initial activation of p34(cdc2)/cyclin B, which initiates mitosis through the activation of Cdc25C.
在存在能量源的情况下于30℃孵育,在从温度敏感突变体tsBN2制备的提取物中,p34(cdc2)/细胞周期蛋白B被激活,tsBN2在40℃(非允许温度)时会过早进入有丝分裂(Nishimoto, T., E. Eilen, and C. Basilico. 1978. Cell. 15:475 - 483),以及仓鼠BHK21细胞系中处于S期停滞的野生型细胞,且无需蛋白质合成。然而,在用蛋白质合成抑制剂环己酰亚胺预处理的细胞制备的提取物中,p34(cdc2)/细胞周期蛋白B并未发生这种体外激活,尽管该提取物仍保留抑制p34(cdc2)/细胞周期蛋白B激活的能力。当处于S期停滞的tsBN2细胞在存在环己酰亚胺的情况下于40℃孵育时,在双特异性磷酸酶家族Cdc25中,Cdc25B而非Cdc25A和C与p34(cdc2)/细胞周期蛋白B缺乏激活同时消失。一致地,从提取物中免疫去除Cdc25B会抑制p34(cdc2)/细胞周期蛋白B的激活。发现Cdc25B不稳定(半衰期<30分钟)。从提取物中免疫沉淀的Cdc25B直接激活了环己酰亚胺处理细胞以及未处理细胞的p34(cdc2)/细胞周期蛋白B,尽管从有丝分裂细胞提取物中免疫沉淀的Cdc25C激活了环己酰亚胺处理细胞提取物中的p34(cdc2)/细胞周期蛋白B。我们的数据表明,Cdc25B对p34(cdc2)/细胞周期蛋白B进行了初始激活,该激活通过Cdc25C的激活启动有丝分裂。